Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by webpiloton Nov 28, 2007 12:18pm
271 Views
Post# 13881065

Will Buy in at .15

Will Buy in at .15I am ready to commit funds to a long position, but not at this inflated price. My buy target is .15. There are way tooo many shares outstanding, and even though there has been a recent offering, there is relatively little cash to sustain the company. Money will disappear rapidly. Little stock trading since the recent news releases, I look for continued downward pressure on the stock.
Bullboard Posts